ACTRN12617001190392招募中1 期
An open label phase IB/II, non-randomised, dose-finding, safety and tolerability study of Panitumumab, Irinotecan, Trifluridine/Tipiracil in RAS wild-type patients with metastatic colorectal cancer
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
A study to assess the safety and distribution of GDC-8264 in combination with standard of care corticosteroid treatment in the blood of participants with high-risk acute graft-versus-host disease (aGVHD)ISRCTN27200385Genentech, Inc.40
进行中（未招募）
1 期
A Phase 1/2a gene therapy clinical trial in Retinitis Pigmentosa subjectsRetinitis PigmentosaEUCTR2017-002204-27-GBGENSIGHT-BIOLOGICS18
进行中（未招募）
1 期
A Phase 1/2a gene therapy clinical trial in Retinitis Pigmentosa subjects.Retinitis PigmentosaMedDRA version: 20.0Level: PTClassification code: 10038914Term: Retinitis pigmentosa Class: 100000004850CTIS2024-516059-42-00Gensight Biologics18
进行中（未招募）
1 期
A study in which two antibiotics (vancomycin and fidaxomicin) are compared in older patients with infections of the gut caused by bacteria called Clostridium difficile.Clostridium Difficile Infection (CDI) also known as C. difficile-associated diarrhoea (CDAD)MedDRA version: 17.1Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 100000004862EUCTR2013-004619-31-DEAstellas Pharma Europe Ltd.364
进行中（未招募）
1 期
A study in which two antibiotics (vancomycin and fidaxomicin) are compared in older patients with infections of the gut caused by bacteria called Clostridium difficile.Clostridium Difficile Infection (CDI) also known as C. difficile-associated diarrhoea (CDAD)MedDRA version: 18.1Level: LLTClassification code 10022661Term: Intestinal infection due to clostridium difficileSystem Organ Class: 100000004862EUCTR2013-004619-31-ATAstellas Pharma Europe Ltd.364